Rate of Primary Refractory Disease in B and T-Cell Non-Hodgkin’s Lymphoma: Correlation with Long-Term Survival

Primary Non-Hodgkin’s Lymphoma of the Uterine Cervix: Case Report of Long-Term Survival Patient

The Journal of Obstetrics and Gynecology of India ◽

10.1007/s13224-013-0483-2 ◽

2013 ◽

Vol 64 (S1) ◽

pp. 145-147

Author(s):

N. Mouhajir ◽

A. Diakité ◽

A. Toulba ◽

M. Hemmich ◽

I. Saadi ◽

...

Keyword(s):

Case Report ◽

Uterine Cervix ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

TWO-DECADE EXPERIENCE AND LONG-TERM SURVIVAL IN PEDIATRIC NON-HODGKIN'S LYMPHOMA

PEDIATRICS ◽

10.1542/peds.2007-2022xxx ◽

2008 ◽

Vol 121 (Supplement 2) ◽

pp. S121.3-S122

Author(s):

Vassilios Papadakis ◽

Agapi Parcharidou ◽

Anna Paisiou ◽

Natalia Tourkantoni ◽

Sofia Papargyri ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Primary non‐Hodgkin's lymphoma of the uterine cervix: Case report of long‐term survival of two patients treated with surgery and radiotherapy

Australasian Radiology ◽

10.1111/j.1440-1673.1998.tb00587.x ◽

1998 ◽

Vol 42 (2) ◽

pp. 126-127 ◽

Cited By ~ 8

Author(s):

KM Lee ◽

ES Seah ◽

VK Sethi

Keyword(s):

Case Report ◽

Uterine Cervix ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Long-Term Survival Following Non-Hodgkin's Lymphoma Arising in Wiskott–Aldrich Syndrome

Clinical Oncology ◽

10.1053/clon.1999.9066 ◽

1999 ◽

Vol 11 (4) ◽

pp. 283-285 ◽

Cited By ~ 5

Author(s):

D Gilson ◽

R.E Taylor

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Wiskott Aldrich Syndrome ◽

Surface marker and histopathologic correlation with long-term survival in advanced large-cell non-Hodgkin's lymphoma

Cancer ◽

10.1002/1097-0142(19810315)47:6<1329::aid-cncr2820470616>3.0.co;2-x ◽

1981 ◽

Vol 47 (6) ◽

pp. 1329-1335 ◽

Cited By ~ 21

Author(s):

Richard A. Rudders ◽

Ernest T. Ahl ◽

Ronald A. Delellis

Keyword(s):

Hodgkin’S Lymphoma ◽

Large Cell ◽

Surface Marker ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Long-term survival advantage of MACOP-B over CHOP in intermediate-grade non-Hodgkin's lymphoma

Annals of Oncology ◽

10.1093/annonc/8.suppl_1.s71 ◽

1997 ◽

Vol 8 ◽

pp. S71-S75 ◽

Cited By ~ 11

Author(s):

M. Wolf ◽

J.P. Matthews ◽

J. Stone ◽

I.A. Cooper ◽

T.I. Robertson ◽

...

Keyword(s):

Hodgkin’S Lymphoma ◽

Survival Advantage ◽

Hodgkin's Lymphoma ◽

Intermediate Grade ◽

Term Survival ◽

Long Term Survival ◽

Autologous bone marrrow transplantation versus chemotherapy in relapsed/refractory non-hodgkin's lymphoma: Estimates of long-term survival from the recent literatur

American Journal of Hematology ◽

10.1002/ajh.2830500208 ◽

1995 ◽

Vol 50 (2) ◽

pp. 116-123 ◽

Cited By ~ 8

Author(s):

Kenneth R. Meehan ◽

Robert S. Pritchard ◽

Joshua W. Leichter ◽

Benjamin Littenberg ◽

H. Gilbert Welch

Keyword(s):

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin's Lymphoma ◽

Autologous Bone

Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2003.11.001 ◽

2004 ◽

Vol 59 (2) ◽

pp. 501-508 ◽

Cited By ~ 64

Author(s):

Eric M Bessell ◽

Francesc Graus ◽

Armando Lopez-Guillermo ◽

Sarah A Lewis ◽

Salvador Villa ◽

...

Keyword(s):

Prognostic Factors ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Term Survival ◽

Long Term Survival ◽

WITHDRAWN: Addition of amifostine to CHOP regimen significantly reduced toxicity in patients with aggressive non-Hodgkin’s lymphoma without affecting the long term survival: Results of a phase II trial

Hematology/Oncology and Stem Cell Therapy ◽

10.1016/j.hemonc.2012.10.001 ◽

2013 ◽

Author(s):

Henry L. Gómez

Keyword(s):

Phase Ii ◽

Hodgkin’S Lymphoma ◽

Phase Ii Trial ◽

Hodgkin's Lymphoma ◽

Chop Regimen ◽

Term Survival ◽

Long Term Survival ◽

Non Hodgkin's Lymphoma ◽

Reduced Toxicity

Non Hodgkin’s Lymphoma T cell (PTCL-NOS) Post Salvage Radiation, a Long Term Survivor

British Journal of Cancer Research ◽

10.31488/bjcr.164 ◽

2021 ◽

Vol 4 (1) ◽

Keyword(s):

T Cell ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Non Hodgkin's Lymphoma ◽

Term Survivor